Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
TER
0,35% p.a.
Distributiebeleid
Distribution
Replicatie
Physique
Fondsgrootte
EUR 70 m
Startdatum
5 mars 2018
Bedrijven
250
Advertisement
Je kapitaal loopt risico. Meer informatie en voorwaarden op trading212.com
Overzicht
Advertisement
Beleg met Trading 212: 4,20 % rente op euro's en beleg in 12.000+ aandelen & ETF's. Account openen* Je kapitaal loopt risico. Meer informatie en voorwaarden op trading212.com
Beschrijving
Le iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) reproduit l'index Nasdaq Biotechnology. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
Grafiek
Basis
Data
| Index | Nasdaq Biotechnology |
| Investeringsfocus | Actions, États-Unis, Santé |
| Fondsgrootte | EUR 70 m |
| Totale kostenratio (TER) | 0,35% p.a. |
| Replicatie | Fysiek (Geoptimaliseerde sampling) |
| Juridische structuur | ETF |
| Beleggingsaanpak | Langdurig |
| Duurzaamheid | Non |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 21,82% |
| Startdatum/Noteringsdatum | 5 mars 2018 |
| Distributiebeleid | Distribueren |
| Distributiefrequentie | Halfjaarlijks |
| Vestigingsplaats van het fonds | Irlande |
| Fondsaanbieder | iShares |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | State Street Fund Services (Ireland) Limited |
| Beleggingsadviseur | |
| Bewaarbank | State Street Custodial Services (Ireland) Limited |
| Revisiebedrijf | Deloitte |
| Einde belastingjaar | 31 mai |
| Vertegenwoordiger van Zwitserland | BlackRock Asset Management Schweiz AG |
| Zwitserse uitbetalende instantie | State Street Bank International GmbH, Munich, Zurich Branch |
| Duitsland | 30% d’exonération partielle |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Meldefonds |
| UK | UK Reporting |
| Italië | 26,0% |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Effectenlening | Yes |
| Tegenpartij die effecten uitleent | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Top 10 holdings
Weging van top 10-holdings
van 250
44,15%
| Amgen, Inc. | 8,66% |
| Vertex Pharmaceuticals | 8,26% |
| Gilead Sciences, Inc. | 7,39% |
| Regeneron Pharmaceuticals, Inc. | 5,33% |
| Moderna | 3,60% |
| Revolution Medicines | 2,83% |
| Illumina, Inc. | 2,09% |
| Alnylam Pharmaceuticals | 2,08% |
| Biogen | 2,07% |
| argenx | 1,84% |
Vanaf 31/08/2026
Prestaties
Les chiffres de performance incluent les distributions ou les dividendes, le cas échéant. Par défaut, la performance totale de l'ETF est affichée.
Rendementsoverzicht
| YTD | +29,89% |
| 1 maand | +3,52% |
| 3 maanden | +11,63% |
| 6 maanden | +21,59% |
| 1 jaar | +39,81% |
| 3 jaar | +77,83% |
| 5 jaar | +51,33% |
| Since inception | +126,60% |
| 2025 | +17,31% |
| 2024 | +5,34% |
| 2023 | +0,76% |
| 2022 | -5,13% |
Maandelijks rendement in een heat map
Dividenden
Huidig dividendrendement
| Rendement actuel de distribution | 0,21% |
| Dividenden (laatste 12 maanden) | EUR 0,02 |
Historische dividendopbrengsten
| Periode | Dividend in EUR | Dividendrendement in % |
|---|---|---|
| 1 an | EUR 0,02 | 0,29% |
| 2025 | EUR 0,03 | 0,44% |
| 2024 | EUR 0,03 | 0,47% |
| 2023 | EUR 0,02 | 0,40% |
| 2022 | EUR 0,03 | 0,42% |
Bijdrage dividendrendement
Maandelijkse dividenden
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 21,82% |
| Volatiliteit 3 jaar | 21,49% |
| Volatiliteit 5 jaar | 22,80% |
| Rendement/Risico 1 jaar | 1,82 |
| Rendement/Risico 3 jaar | 0,98 |
| Rendement/Risico 5 jaar | 0,38 |
| Maximaal waardedaling 1 jaar | -7,03% |
| Maximaal waardedaling 3 jaar | -25,58% |
| Maximaal waardedaling 5 jaar | -28,50% |
| Maximaal waardedaling sinds aanvang | -31,04% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | OM3E | - - | - - | - |
| London Stock Exchange | USD | BTEE | BTEE LN INAVBTDU | BTTE.L |
Meer informatie
Verdere ETF op de Nasdaq Biotechnology-index
| Naam fonds | Fondsgrootte in €m (AuM) | TER p.j. | Distributie | Replicatiemethode |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 1.038 | 0,35% p.a. | Accumulerend | Sampling |
| Invesco Nasdaq Biotech UCITS ETF | 498 | 0,40% p.a. | Accumulerend | Swap-gebaseerd |
Nieuwste artikelen
Veelgestelde vragen
What is the name of BTEE?
The name of BTEE is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
What is the ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?
The primary ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is BTEE.
What is the ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?
The ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is IE00BDZVHG35.
What are the costs of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?
The total expense ratio (TER) of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) amounts to 0,35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) paying dividends?
Yes, iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is paying dividends. Usually, the dividend payments take place une fois par semestre for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
What's the fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?
The fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is 70m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.